Position in PAHC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$165
-$1,788 QoQ
Shares Held
3
-98.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
|
13,278 | $695,767 |
All Filings in PAHC
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $165 | 3 | Shares | Sole | 2026-05-13 | |
| 2023-09-30 | $1,953 | 153 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,959 | 216 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,309 | 216 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,051 | 153 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,007 | 452 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,525 | 132 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $877 | 44 | Shares | Sole | 2022-05-06 | |
| 2021-09-30 | $1,335 | 62 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $2,154 | 82 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,980 | 82 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||